PAM
ANIP icon

Princeton Alpha Management’s ANI Pharmaceuticals ANIP Stock Holding History

Princeton Alpha Management’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-5,044
Closed -$228K – 720
2015
Q4 		$228K Buy
+5,044
New +$217K 0.04% 586

Other funds holding ANIP

CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
HVC
Healthcare Value Capital Woodcliff Lake, New Jersey $50.7M AUM 24.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SAM
Senzar Asset Management New York $34.7M AUM 0.56% 1-Year Est. Return
ACM
Apex Capital Management Dayton, Ohio $4.54B AUM 1.74% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $123B AUM 45.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Skandinaviska Enskilda Banken (SEB)
Skandinaviska Enskilda Banken (SEB) Stockholm, Sweden $2.66B AUM 26.2% 1-Year Est. Return

Princeton Alpha Management's ANIP Position: Q1 2016 in Review

Princeton Alpha Management sold out of ANI Pharmaceuticals (ANIP) in Q1 2016, closing a stake of 5,044 shares — an estimated $228K sold.

Princeton Alpha Management first reported a position in ANIP in Q4 2015 and held it in 1 quarter. The position peaked at $228K in Q4 2015. 121 funds tracked by Wall St. Rank hold ANIP as of Q1 2016.

  • Princeton Alpha Management reported no remaining ANI Pharmaceuticals position as of Q1 2016 after selling out during the quarter.
  • Princeton Alpha Management sold 5,044 ANI Pharmaceuticals shares in Q1 2016, an estimated $228K.
  • Princeton Alpha Management first reported a position in ANI Pharmaceuticals in Q4 2015 and held it in 1 quarter.
  • Princeton Alpha Management's ANI Pharmaceuticals position peaked at $228K in Q4 2015.
  • 121 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q1 2016.

Based on Princeton Alpha Management's 13F filing for Q1 2016, filed 5 May 2016.